1-2 of 2
D.Y. Zang, MD
Close
Sort by
Journal Articles

The Intention To Treat Analysis of the Different Post Remission Therapy Modalities in AML Patients with the “Intermediate Risk Group (IPG)” Based on Cytogenetics.

Yeung-Chul Mun, MD, S.M. Lee, MD, S.H. Park, MD, E.K. Cho, MD, J.H. Lee, MD, D.Y. Jo, MD, I.H. Kim, MD, S.S. Yoon, MD, S.Y. Park, MD, S.M. Bang, MD, Y.J. Min, MD, J.J. Seo, MD, M.H. Lee, MD, C.S. Kim, MD, Y.D. Joo, MD, S.Y. Chung, MD, D.Y. Oh, MD, D.Y. Zang, MD, K.H. Lee, MD, M.S. Hyun, MD, H.S. Song, MD, H.S. Kim, MD, H.C. Kwon, MD, H.J. Kim, MD, Y.H. Park, MD, M.J. Ahn, MD, J.S. Ahn, MD, K.T. Park, MD, S.H. Bae, MD, H.M. Ryoo, MD, H.J. Yoon, MD, B.S. Kim, MD, Thad Ghim, MD, Chu-Myong Seong, MD
Journal: Blood
Blood (2006) 108 (11): 4563.
https://doi.org/10.1182/blood.V108.11.4563.4563
Published: 2006
Journal Articles

Interim Anaiysis of Intention To Treat Analysis, “Multicenter AML-2000 Trial” Based on Cytogenetics Risk Factors.

Yeung-Chul Mun, MD, S.M. Lee, MD, S.M. Bang, MD, S.H. Park, MD, E.K. Cho, MD, J.H. Lee, MD, D.Y. Jo, MD, S.Y. Kim, MD, I.H. Kim, MD, S.S. Yoon, MD, S.Y. Park, MD, B.K. Kim, MD, Y.J. Min, MD, J.J. Seo, MD, Thad Ghim, MD, M.H. Lee, MD, C.S. Kim, MD, Y.D. Joo, MD, S.Y. Chung, MD, D.Y. Oh, MD, J.S. Ahn, MD, D.Y. Zang, MD, K.H. Lee, MD, M.K. Kim, MD, M.S. Hyun, MD, H.S. Song, MD, H.S. Kim, MD, H.C. Kwon, MD, H.J. Kim, MD, K.T. Park, MD, S.H. Bae, MD, H.M. Ryoo, MD, M.J. Ahn, MD, H.J. Yoon, MD, B.S. Kim, MD, Y.H. Park, MD, C.M. Seong, MD
Journal: Blood
Blood (2005) 106 (11): 4618.
https://doi.org/10.1182/blood.V106.11.4618.4618
Published: 2005